Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP2018 in Young, Depressed, Erectile Dysfunction Patients
NCT04686916Phase 2Unknown
- Sponsor
- Initiator Pharma A/S
- Start
- Dec 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IP2018 in erectile dysfunction (ED), sponsored by Initiator Pharma A/S. Status: unknown.
02
Drugs
IP2018
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04686916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686916.